BamSEC and AlphaSense Join Forces
Learn More

Phio Pharmaceuticals Corp.

NASDAQ: PHIO    
Share price (10/21/25): $2.13    
Market cap (10/21/25): $12.2 million

Material Contracts Filter

EX-10.3
from 10-Q 8 pages Separation Agreement and General Release of Claims, Dated August 11, 2025, by and Between the Company and Robert Infarinato.
12/34/56
EX-10.2
from 10-Q 15 pages Indemnification Agreement
12/34/56
EX-10.1
from 8-K 8 pages Holder of Common Stock Purchase Warrants Re: Inducement Offer to Exercise Common Stock Purchase Warrants Dear Holder
12/34/56
EX-10.1
from 8-K 9 pages Material contract
12/34/56
EX-10.30
from 10-K 1 page First Amendment to the Employment Agreement of Robert J. Bitterman
12/34/56
EX-10.1
from 8-K 34 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 34 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 32 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 31 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 31 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 9 pages Material contract
12/34/56
EX-10.1
from 8-K 8 pages Holder of Common Stock Purchase Warrants Re: Inducement Offer to Exercise Common Stock Purchase Warrants Dear Holder
12/34/56
EX-10.1
from 8-K 20 pages Phio Pharmaceuticals Corp. 2020 Long Term Incentive Plan
12/34/56
EX-10.1
from 8-K 18 pages Purchase Agreement
12/34/56
EX-10.1
from 8-K 7 pages December 6, 2023 Holder of Common Stock Purchase Warrants Re: Inducement Offer to Exercise Common Stock Purchase Warrants Dear Holder
12/34/56
EX-10.2
from 10-Q 6 pages Phio Pharmaceuticals Corp. 2020 Long Term Incentive Plan Nonqualified Stock Option Award Agreement
12/34/56
EX-10.1
from 10-Q 16 pages Phio Pharmaceuticals Corp. 2020 Long Term Incentive Plan
12/34/56
EX-10.1
from 8-K 16 pages Phio Pharmaceuticals Corp. 2020 Long Term Incentive Plan
12/34/56
EX-10.3
from 8-K 14 pages Registration Rights Agreement
12/34/56
EX-10.2
from 8-K 32 pages Securities Purchase Agreement
12/34/56